Opebacan

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOpebacan
Drug Alias NameRecombinant bactericidal permeability increasing protein 21BPI 21rBPI21Neuprex
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAngiogenesis inhibitorsCell membrane permeability enhancers
TargetsLipopolysaccharide (LPS)
Therapy Area/IndicationsRadiation InjuriesBurnsGraft vs Host Disease +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesXoma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Texas Southwestern Medical CenterXoma CorpXoma (Us) Llc
Active IndicationsN/A
Inactive IndicationsRadiation InjuriesBurnsGraft vs Host Disease +[6] 

Other Information

ATC CodeN/A
Related LinksDrugBank